Use of memantine (namenda) to treat autism, compulsivity,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01)

Patent

CA 2580619

The present invention relates to the treatment of compulsive, impulsive and pervasive developmental disorders. More particularly, the methods described herein comprise administration of memantine to an individual suffering from such a disorder in an amount effective to relieve one or more symptoms of said disorder. In particularly preferred aspects, the invention is directed to the use of memantine for the treatment of autism

L'invention concerne le traitement de troubles du développement de type compulsifs, impulsifs et envahissants. L'invention concerne en particulier des méthodes consistant à administrer de la mémantine à un individu souffrant d'un tel trouble, en quantité suffisante pour le soulager d'un ou de plusieurs symptômes dudit trouble. Dans des modes de réalisation préférés, l'invention concerne l'utilisation de mémantine pour traiter l'autisme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of memantine (namenda) to treat autism, compulsivity,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of memantine (namenda) to treat autism, compulsivity,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of memantine (namenda) to treat autism, compulsivity,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1818455

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.